Trevi Therapeutics Inc (TRVI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 8,089 | 9,193 | 7,244 | 7,413 | 8,639 |
| Operating Income | -8,089 | -9,193 | -7,244 | -7,413 | -8,639 |
| Interest Expense | 294 | 308 | 148 | 0 | 0 |
| Other Income | -3 | -5 | 3 | 14 | 157 |
| Pre-tax Income | -8,386 | -9,506 | -7,389 | -7,399 | -8,482 |
| Income Tax | -15 | 17 | -11 | -15 | -9 |
| Net Income Continuous | -8,371 | -9,523 | -7,378 | -7,384 | -8,473 |
| Net Income | $-8,371 | $-9,523 | $-7,378 | $-7,384 | $-8,473 |
| EPS Basic Total Ops | -0.43 | -0.51 | -0.41 | -0.41 | -0.48 |
| EPS Basic Continuous Ops | -0.43 | -0.52 | -0.41 | -0.41 | -0.48 |
| EPS Diluted Total Ops | -0.43 | -0.51 | -0.41 | -0.41 | -0.48 |
| EPS Diluted Continuous Ops | -0.43 | -0.52 | -0.41 | -0.41 | -0.48 |
| EBITDA(a) | $-7,931 | $-9,021 | $-7,163 | $-7,402 | $-8,629 |